To determine the source of CD34-derived fibroblasts in a model of hypertension combined with hyperlipidemia, bone marrow transplantation was performed, and the results indicated that non-bone marrow CD34+ cells can differentiate into Fabp4+ fibroblasts and may be the major participants in cardiac fibrosis. This evidence concerns the gene CD34 and hyperlipidemia.